Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | adenosine A2a receptor | Starlite/ChEMBL | References |
Homo sapiens | adenosine A3 receptor | Starlite/ChEMBL | References |
Homo sapiens | adenosine A1 receptor | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Brugia malayi | follicle stimulating hormone receptor | adenosine A2a receptor | 412 aa | 336 aa | 22.3 % |
Brugia malayi | hypothetical protein | adenosine A1 receptor | 326 aa | 305 aa | 21.0 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trypanosoma brucei | pyruvate kinase 1 | 0.0457 | 0.3068 | 0.1947 |
Echinococcus multilocularis | pyruvate kinase | 0.0457 | 0.3068 | 0.3068 |
Mycobacterium leprae | Probable pyruvate kinase PykA | 0.0457 | 0.3068 | 0.5 |
Echinococcus multilocularis | Pyruvate dehydrogenase (lipoamide) kinase | 0.0959 | 1 | 1 |
Schistosoma mansoni | pyruvate kinase | 0.0457 | 0.3068 | 0.3068 |
Schistosoma mansoni | pyruvate dehydrogenase | 0.0905 | 0.9264 | 0.9264 |
Mycobacterium tuberculosis | Probable pyruvate kinase PykA | 0.0457 | 0.3068 | 0.5 |
Echinococcus granulosus | Pyruvate dehydrogenase lipoamide kinase | 0.0959 | 1 | 1 |
Schistosoma mansoni | pyruvate dehydrogenase | 0.0959 | 1 | 1 |
Onchocerca volvulus | Pyruvate kinase homolog | 0.0457 | 0.3068 | 0.5 |
Echinococcus multilocularis | pyruvate kinase | 0.0457 | 0.3068 | 0.3068 |
Trypanosoma cruzi | pyruvate kinase 2, putative | 0.0457 | 0.3068 | 0.1947 |
Loa Loa (eye worm) | hypothetical protein | 0.0457 | 0.3068 | 0.2157 |
Echinococcus granulosus | pyruvate kinase | 0.0457 | 0.3068 | 0.3068 |
Onchocerca volvulus | Pyruvate kinase homolog | 0.0457 | 0.3068 | 0.5 |
Onchocerca volvulus | Pyruvate kinase homolog | 0.0457 | 0.3068 | 0.5 |
Plasmodium falciparum | pyruvate kinase | 0.0457 | 0.3068 | 1 |
Echinococcus multilocularis | pyruvate kinase | 0.036 | 0.174 | 0.174 |
Toxoplasma gondii | ATPase/histidine kinase/DNA gyrase B/HSP90 domain-containing protein | 0.0389 | 0.2128 | 0.6937 |
Echinococcus multilocularis | Pyruvate dehydrogenase (lipoamide) kinase | 0.0959 | 1 | 1 |
Loa Loa (eye worm) | pyruvate kinase | 0.0457 | 0.3068 | 0.2157 |
Trypanosoma cruzi | developmentally regulated phosphoprotein, putative | 0.0959 | 1 | 1 |
Toxoplasma gondii | pyruvate dehydrogenase kinase, putative | 0.0335 | 0.1392 | 0.4537 |
Loa Loa (eye worm) | pyruvate kinase | 0.0457 | 0.3068 | 0.2157 |
Trichomonas vaginalis | pyruvate kinase, putative | 0.0457 | 0.3068 | 0.5 |
Leishmania major | pyruvate kinase | 0.0457 | 0.3068 | 0.1947 |
Loa Loa (eye worm) | hypothetical protein | 0.0959 | 1 | 1 |
Loa Loa (eye worm) | pyruvate kinase | 0.0457 | 0.3068 | 0.2157 |
Mycobacterium ulcerans | pyruvate kinase | 0.0457 | 0.3068 | 0.5 |
Giardia lamblia | Pyruvate kinase | 0.0457 | 0.3068 | 1 |
Chlamydia trachomatis | pyruvate kinase | 0.0457 | 0.3068 | 0.5 |
Toxoplasma gondii | pyruvate kinase PyK1 | 0.0457 | 0.3068 | 1 |
Trypanosoma brucei | developmentally regulated phosphoprotein | 0.0959 | 1 | 1 |
Schistosoma mansoni | pyruvate kinase | 0.0457 | 0.3068 | 0.3068 |
Plasmodium vivax | pyruvate kinase, putative | 0.0457 | 0.3068 | 1 |
Leishmania major | developmentally regulated phosphoprotein-like protein | 0.0959 | 1 | 1 |
Echinococcus granulosus | pyruvate kinase | 0.0457 | 0.3068 | 0.3068 |
Leishmania major | pyruvate kinase | 0.0457 | 0.3068 | 0.1947 |
Schistosoma mansoni | pyruvate dehydrogenase | 0.0905 | 0.9264 | 0.9264 |
Entamoeba histolytica | pyruvate kinase, putative | 0.0318 | 0.1161 | 0.5 |
Trypanosoma cruzi | pyruvate kinase 2, putative | 0.0457 | 0.3068 | 0.1947 |
Trypanosoma brucei | pyruvate kinase 1, putative | 0.0457 | 0.3068 | 0.1947 |
Trichomonas vaginalis | pyruvate kinase, putative | 0.0457 | 0.3068 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (functional) | > 100000 nM | Antagonist activity at human recombinant adenosine A2B receptor expressed in CHO cells assessed as inhibition of NECA-stimulated adenylyl cyclase activity | ChEMBL. | 21214204 |
Ki (binding) | = 39.1 nM | Displacement of [3H]ZM241385 from human adenosine A2A receptor expressed in HEK293 cells by scintillation counting | ChEMBL. | 21214204 |
Ki (binding) | = 991 nM | Displacement of [3H]DPCPX from human adenosine A1 receptor expressed in HEK293 cells by scintillation counting | ChEMBL. | 21214204 |
Ki (binding) | = 1260 nM | Displacement of [I125]I-AB-MECA from human adenosine A3 receptor expressed in CHO cells by scintillation counting | ChEMBL. | 21214204 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.